These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10155348

  • 1. Cost considerations in oral antibiotic therapy.
    Ballow CH.
    Adv Ther; 1995; 12(4):199-206. PubMed ID: 10155348
    [Abstract] [Full Text] [Related]

  • 2. Cost of oral antibiotic therapy.
    Nightingale CH, Quintiliani R.
    Pharmacotherapy; 1997; 17(2):302-7. PubMed ID: 9085322
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A.
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [Abstract] [Full Text] [Related]

  • 4. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ, Trilla A, Codina C, Carné X, Ribas J, Asenjo MA.
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [Abstract] [Full Text] [Related]

  • 5. Future pharmacoeconomic criteria for the treatment of infections.
    Milkovich G.
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S12-4. PubMed ID: 19560668
    [Abstract] [Full Text] [Related]

  • 6. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ.
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [Abstract] [Full Text] [Related]

  • 7. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
    Conney J, Kaston B.
    Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW, Duquaine SM, McKinnon PS.
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [Abstract] [Full Text] [Related]

  • 9. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L, Encinas MP, Morín LS, Vilches P, Gutiérrez N, García-Sanz R, Caballero D, Hurlé AD.
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [Abstract] [Full Text] [Related]

  • 10. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J.
    Acta Pol Pharm; 2005 Mar; 62(6):485-90. PubMed ID: 16583989
    [Abstract] [Full Text] [Related]

  • 11. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J.
    Acta Pol Pharm; 2005 Mar; 62(6):491-5. PubMed ID: 16583990
    [Abstract] [Full Text] [Related]

  • 12. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
    Rüttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC.
    Clin Infect Dis; 2004 Feb 01; 38(3):348-56. PubMed ID: 14727204
    [Abstract] [Full Text] [Related]

  • 13. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ, Anzueto A.
    Am J Med; 2005 Jul 01; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Single daily dose and simplified dosing regimens as a method to improve antibiotic therapy.
    McDaniel A.
    Pharm Pract Manag Q; 1996 Jul 01; 16(2):57-61. PubMed ID: 10161613
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacoeconomics of intravenous antibiotic use in serious infection.
    Levett PN, Jennings AM, Manning KS, Harewood HC, Griffith CR, Williams CJ, Estwick D, Lashley BA.
    West Indian Med J; 1995 Sep 01; 44(3):81-4. PubMed ID: 8560883
    [Abstract] [Full Text] [Related]

  • 18. Parameters important in short antibiotic courses.
    Pechère JC.
    J Int Med Res; 2000 Sep 01; 28 Suppl 1():3A-12A. PubMed ID: 11092225
    [Abstract] [Full Text] [Related]

  • 19. Oral antibiotics: practical prescribing rules for practitioners.
    McCue JD.
    Geriatrics; 1992 Jul 01; 47(7):59-60, 65-6. PubMed ID: 1618399
    [Abstract] [Full Text] [Related]

  • 20. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.
    Clin Ther; 2008 Feb 01; 30(2):358-71. PubMed ID: 18343274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.